Overview of Brain Tumor Epidemiology

Handbook of Neuro-Oncology Neuroimaging

Volumn , Issue , 2008, Pages 3-8

  Newton, Herbert B ^a   Malkin, Mark G ^b  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79955695553     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012370863-2.50003-8     Document Type: Chapter

References (60)

1. Newton HB Primary brain tumors: review of etiology, diagnosis, and treatment. Am Fam Phys 1994, 49:787-797.
2. Preston-Martin S Epidemiology of primary CNS neoplasms. Neurol Clin 1996, 14:273-290.
3. Davis FG, McCarthy BJ Current epidemiological trends and surveillance issues in brain tumors. Expert Rev Anticancer Ther 2001, 1:395-401.
4. Osborne RH, Houben MPWA, Tijssen CC, Coebergh JWW, van Duijn CM The genetic epidemiology of glioma. Neurology 2001, 57:1751-1755.
5. Wrensch M, Minn Y, Chew T, Bondy M, Berger MS Epidemiology of primary brain tumors: current concepts and review of the literature. Neuro-Oncology 2002, 4:278-299.
6. Hess KR, Broglio DR, Bondy ML Adult glioma incidence trends in the United States, 1977-2000. Cancer 2004, 101:2293-2299.
7. Newton HB Neurological complications of systemic cancer. Am Fam Phys 1999, 59:878-886.
8. Soffietti R, Ruda R, Mutani R Management of brain metastases. J Neurol 2002, 249:1357-1369.
9. Langer CJ, Mehta MP Current management of brain metastases, with a focus on systemic options. J Clin Oncol 2005, 23:6207-6219.
10. Bajaj GK, Kleinberg L, Terezakis S Current concepts and controversies in the treatment of parenchymal brain metastases: improved outcomes with aggressive management. Cancer Invest 2005, 23:363-376.
11. Lassman AB, DeAngelis LM Brain metastases. Neurol Clin N Am 2003, 21:1-23.
12. Legler JM, Ries LA, Smith MA Cancer surveillance series [corrected]: brain and other central nervous system cancers: recent trends in incidence and mortality. J Natl Cancer Inst 1999, 91:1382-1390.
13. Cancer Facts and Figures 2002. American Cancer Society, Atlanta 2002, ACS (American Cancer Society).
14. Grovas A, Fremgen A, Rauck A The National Cancer Data Base report on patterns of childhood cancers in the United States. Cancer 1997, 80:2321-2332.
15. Bondy M, Wiencke J, Wrensch M, Kryitsis AP Genetics of primary brain tumors: a review. J Neuro-Oncol 1994, 18:69-81.
16. de Andrade M, Barnholtz JS, Amos CI, Adatto P, Spencer C, Bondy ML Segregation analysis of cancer in families of glioma patients. Genet Epidemiol 2001, 20:258-270.
17. Malmer B, Gronberg H, Bergenheim AT, Lenner P, Henriksson R Familial aggregation of astrocytoma in northern Sweden: an epidemiological cohort study. Int J Cancer 1999, 81:366-370.
18. Elexpuru-Camiruaga J, Buxton N, Kandula V Susceptibility to astrocytoma and meningioma: infl uence of allelism at glutathione S-transferase (GSTT1 and GSTM1) and cytochrome P-450 (CYP2D6) loci. Cancer Res 1995, 55:4237-4239.
19. Trizna Z, de Andrade AP, Kyritsis M, et al. Genetic polymorphisms in glutathione S-transferase mu and theta, N-acetyltransferase, and CYP1A1 and risk of gliomas. Cancer Epidemiol Biomarkers Prev 1998, 7:553-555.
20. Karlsson P, Holmberg E, Lundell M, Mattsson A, Holm LE, Wallgren A Intracranial tumors after exposure to ionizing radiation during infancy: a pooled analysis of two Swedish cohorts of 28 008 infants with skin hemangioma. Radiat Res 1998, 150:357-364.
21. Salvatai M, Aratico M, Caruso R, Rocchi G, Orlando EER, Nucci F A report on radiation-induced gliomas. Cancer 1991, 67:392-397.
22. Yeh H, Matanoski GM, Wang N, Sandler DP, Comstock GW Cancer incidence after childhood nasopharyngeal radium irradiation: a follow-up study in Washington County, Maryland. Am J Epidemiol 2001, 153:749-756.
23. Shintani T, Hayakawa N, Hoshi M High incidence of meningioma among Hiroshima atomic bomb survivors. J Radiat Res 1999, 40:49-57.
24. Loomis DP, Wolf SH Mortality of workers at a nuclear materials production plant at Oak Ridge, Tennessee, 1947-1990. Am J Ind Med 1996, 29:131-141.
25. Wong O, Whorton MD, Follart DE, Ragland D An industry-wide epidemiologic study of vinyl choride workers, 1942-1982. Am J Ind Med 1991, 20:317-334.
26. McLaughlin JK, Lipworth L A critical review of the epidemiologic literature on health effects of occupational exposure to vinyl chloride. J Epidemiol Biostat 1999, 4:253-275.
27. Johansen C, Boice JD, McLaughlin JK, Olsen JH Cellular telephones and cancer - a nationwide cohort study in Denmark. J Natl Cancer Inst 2001, 93:203-207.
28. Muscat JE, Malkin MG, Thompson S Handheld cellular telephone use and risk of brain cancer. J Am Med Assoc 2000, 284:3001-3007.
29. Inskip PD, Tarone RE, Hatch EE Cellulartelephone use and brain tumors. N Engl J Med 2001, 344:79-86.
30. Christensen HC, Schüz J, Kosteljanetz M Cellular telephones and risk for brain tumors. A population-based, incident case-control study. Neurology 2005, 64:1189-1195.
31. Muscat JE, Malkin MG, Shore RE Handheld cellular telephones and risk of acoustic neuroma. Neurology 2002, 58:1304-1306.
32. Schoemaker MJ, Swerdlow AJ, Ahlbom A Mobile phone use and risk of acoustic neuroma: results of the Interphone case-control study in five north European countries. Br J Cancer 2005, 93:842-848.
33. Schuz J, Bohler E, Berg G Cellular phones, cordless phones, and the risks of glioma and meningioma (Interphone Study Group, Germany). Am J Epidemiol 2006, 163:512-520.
34. Wrensch M, Fisher JL, Schwartzbaum JA, Bondy M, Berger M, Aldape KD The molecular epidemiology of gliomas in adults. Neurosurg Focus 2005, 19:E5.
35. Tang J, Shao W, Dorak MT Positive and negative associations of human leukocyte antigen variants with the onset and prognosis of adult glioblastoma multiforme. Cancer Epidemiol Biomarkers Prev 2005, 14:2040-2044.
36. Wrensch M, Kelsey KT, Liu M ERCC1 and ERCC2 polymorphisms and adult gliomas. Neuro-Oncology 2005, 7:495-507.
37. Wiencke JK, Aldape K, McMillan A Molecular features of adult glioma associated with patient race/ethnicity, age, and a polymorphism in O6-methylguanine-DNA-methyltransferase. Cancer Epidemiol Biomarkers Prev 2005, 14:1774-1783.
38. Brenner AV, Linet MS, Fine HA History of allergies and autoimmune diseases and risk of brain tumors in adults. Int J Cancer 2002, 99:252-256.
39. Schwartzbaum J, Ahlbom A, Malmer B Polymorphisms associated with asthma are inversely related to glioblastoma multiforme. Cancer Res 2006, 65:6459-6465.
40. Gavrilovic IT, Posner JB Brain metastases: epidemiology and pathophysiology. J Neuro-Oncol 2005, 75:5-14.
41. Barnhholtz-Sloan JS, Sloan AE, Davis FG, Vigneau FD, Lai P, Sawaya RE Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the metropolitan Detroit Cancer Surveillance System. J Clin Oncol 2004, 22:2865-2872.
42. Leroux PD, Berger MS, Elliott JP, Tamimi HK Cerebral metastases from ovarian carcinoma. Cancer 1991, 67:2194-2199.
43. Martinez-Manas RM, Brell M, Rumia J, Ferrer E Case report. Brain metastases in endometrial carcinoma. Gyn Oncol 1998, 70:282-284.
44. Mccutcheon IE, Eng DY, Logothetis CJ Brain metastasis from prostate carcinoma. Antemortem recognition and outcome after treatment. Cancer 1999, 86:2301-2311.
45. Lowis SP, Foot A, Gerrard MP, et al. Central nervous system metastasis in Wilms' tumor. A review of three consecutive United Kingdom trials. Cancer 1998, 83:2023-2029.
46. Culine S, Bekradda M, Kramar A Prognostic factors for survival in patients with brain metastases from renal cell carcinoma. Cancer 1998, 83:2548-2553.
47. Qasho R, Tommaso V, Rocchi G Choroid plexus metastasis from carcinoma of the bladder: case report and review of the literature. J Neuro-Oncol 1999, 45:237-240.
48. Salvati M, Frati A, Rocchi G Single brain metastasis from thyroid cancer: report of twelve cases and review of the literature. J Neuro-Oncol 2001, 51:33-40.
49. Ogawa K, Toita T, Sueyama H, et al. Brain metastases from esophageal carcinoma. Natural history, prognostic factors, and outcome. Cancer 2002, 94:759-764.
50. Espat NJ, Bilsky M, Lewis JJ, et al. Soft tissue sarcoma brain metastases. Prevalence in a cohort of 33 829 patients. Cancer 2002, 94:2706-2711.
51. Schouten LJ, Rutten J, Huveneers HAM, Twijnstra A Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma. Cancer 2002, 94:2698-2705.
52. Ruda R, Borgognone M, Benech F, Vasario E, Soffietti R Brain metastases from unknown primary tumour. A prospective study. J Neurol 2001, 248:394-398.
53. Kebudi R, Ayan I, Görgün O, Agaoglu FY, Vural S, Darendeliler E Brain metastasis in pediatric extracranial solid tumors: survey and literature review. J Neuro-Oncol 2005, 71:43-48.
54. Hall WA, Djalilian HR, Nussbaum ES Long-term survival with metastatic cancer to the brain. Med Oncol 2000, 17:279-286.
55. Gaspar L, Scott C, Rotman M Recursive partitioning analysis (RPA) of prognostic factors in three radiation therapy oncology group (RTOG) brain metastases trials. Int J Rad Oncol Biol Phys 1997, 37:745-751.
56. Nussbaum ES, Djalilian HR, Cho KH, Hall WA Brain metastases: histology, multiplicity, surgery, and survival. Cancer 1996, 78:1781-1788.
57. Poste G, Fidler IJ The pathogenesis of cancer metastasis. Nature 1980, 283:139-146.
58. Bernards R, Weinberg RA Metastasis genes: a progression puzzle. Nature 2002, 418:823.
59. Ramaswamy S, Ross KN, Lander ES, Golub TR A molecular signature of metastasis in primary solid tumors. Nat Genet 2003, 33:49-54.
60. Milas I, Komaki R, Hachiya T Epidermal growth factor receptor, cyclooxygenase-2, and BAX expression in the primary non-small cell lung cancer and brain metastases. Clin Cancer Res 2003, 9:1070-1076.